Bosutris 100 mg Tablets Bosutris 100 mg Tablets contain bosutinib, a targeted anticancer medicine used to treat Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML). It works by blocking abnormal proteins known as tyrosine kinases that promote the growth and multiplication of leukemia cells. By inhibiting these proteins, the medicine helps slow the progression of the disease and supports better control of blood cell production.

Effects & Benefits Helps slow the growth of leukemia cells. Supports the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). Helps control the abnormal production of white blood cells. May reduce disease progression in eligible patients. Can improve treatment outcomes when taken consistently as prescribed. Supports long-term disease management under the supervision of a hematology specialist. Possible Side Effects

Like all medicines, Bosutris 100 mg Tablets may cause side effects, although not everyone experiences them